The Treatment of Plasmodium knowlesi Malaria

Trends in Parasitology - Tập 33 - Trang 242-253 - 2017
Bridget E. Barber1,2, Matthew J. Grigg1,2, Timothy William2,3,4, Tsin W. Yeo1,2,5,6, Nicholas M. Anstey1,2
1Menzies School of Health Research and Charles Darwin University, PO Box 41096, Casuarina 0810, Northern Territory, Australia
2Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu 88586, Sabah, Malaysia
3Queen Elizabeth Hospital Clinical Research Centre, Kota Kinabalu 88586, Sabah, Malaysia
4Jesselton Medical Centre, Kota Kinabalu, 88300, Sabah, Malaysia
5Lee Kong Chian School of Medicine, Nanyang Technological University, 639798 Singapore
6Communicable Disease Centre, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, 308433 Singapore

Tài liệu tham khảo

Knowles, 1932, A study of monkey-malaria and its experimental transmission to man, Indian Med. Gaz., 67, 246 Singh, 2004, A large focus of naturally acquired Plasmodium knowlesi infections in human beings, Lancet, 363, 1017, 10.1016/S0140-6736(04)15836-4 Rajahram, 2016, Falling Plasmodium knowlesi malaria death rate among adults despite rising incidence, Sabah, Malaysia, 2010-2014, Emerg. Infect. Dis., 22, 41, 10.3201/eid2201.151305 Yusof, 2014, High proportion of knowlesi malaria in recent malaria cases in Malaysia, Malaria J., 13, 168, 10.1186/1475-2875-13-168 William, 2013, Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax malaria in Sabah, Malaysia, PLoS Negl. Trop. Dis., 7, e2026, 10.1371/journal.pntd.0002026 Singh, 2013, Human infections and detection of Plasmodium knowlesi, Clin. Microbiol. Rev., 26, 165, 10.1128/CMR.00079-12 Barber, 2013, A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and P. vivax but no mortality with early referral and artesunate therapy, Clin. Infect. Dis., 56, 383, 10.1093/cid/cis902 Lee, 2009, Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections, Malaria J., 8, 73, 10.1186/1475-2875-8-73 Rajahram, 2012, Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as P. malariae and delayed parenteral artesunate, Malaria J., 11, 284, 10.1186/1475-2875-11-284 Barber, 2013, Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi, Malaria J., 12, 8, 10.1186/1475-2875-12-8 William, 2014, Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi, Malaria J., 13, 390, 10.1186/1475-2875-13-390 Barber, 2013, Evaluation of the sensitivity of a pLDH-based and an aldolase-based rapid diagnostic test for diagnosis of uncomplicated and severe malaria caused by PCR-confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivax, J. Clin. Microbiol., 51, 1118, 10.1128/JCM.03285-12 Grigg, 2014, Combining parasite lactate dehydrogenase-based rapid tests to improve specificity for the diagnosis of malaria due to Plasmodium knowlesi and other Plasmodium species in Sabah, Malaysia. J. Clin. Microbiol., 52, 2053, 10.1128/JCM.00181-14 Fatih, 2013, Susceptibility of human Plasmodium knowlesi infections to anti-malarials, Malaria J., 12, 1186, 10.1186/1475-2875-12-425 Russell, 2008, Determinants of in vitro drug susceptibility testing of Plasmodium vivax, Antimicrob. Agents Chemother., 52, 1040, 10.1128/AAC.01334-07 Kerlin, 2012, An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing, PLoS Negl. Trop. Dis., 6, e1772, 10.1371/journal.pntd.0001772 Ekland, 2008, In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes, Int. J. Parasitol., 38, 743, 10.1016/j.ijpara.2008.03.004 Chaorattanakawee, 2015, Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging piperaquine resistance, Antimicrob. Agents Chemother., 59, 4631, 10.1128/AAC.00366-15 Dahlström, 2014, Plasmodium falciparum polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin, Antimicrob. Agents Chemother., 58, 1, 10.1128/AAC.01790-12 Phompradit, 2014, Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai–Myanmar border, Malaria J., 13, 1, 10.1186/1475-2875-13-23 Lee, 2011, Plasmodium knowlesi: reservoir hosts and tracking the emergence in humans and macaques, PLoS Pathog., 7, e1002105, 10.1371/journal.ppat.1002015 Imai, 2014, Transmission and control of Plasmodium knowlesi: a mathematical modelling study, PLoS Negl. Trop. Dis., 8, e2978, 10.1371/journal.pntd.0002978 Tyagi, 2013, Discordance in drug resistance-associated mutation patterns in marker genes of Plasmodium falciparum and Plasmodium knowlesi during coinfections, J. Antimicrob. Chemother., 68, 1081, 10.1093/jac/dks508 Grigg, 2016, Dihydrofolate-reductase mutations in Plasmodium knowlesi appear unrelated to selective drug pressure from putative human-to-human transmission in Sabah, Malaysia, PLoS ONE, 11, e0149519, 10.1371/journal.pone.0149519 Assefa, 2015, Population genomic structure and adaptation in the zoonotic malaria parasite Plasmodium knowlesi, Proc. Natl. Acad. Sci. U.S.A., 112, 13027, 10.1073/pnas.1509534112 Pinheiro, 2015, Plasmodium knowlesi genome sequences from clinical isolates reveal extensive genomic dimorphism, PLoS ONE, 10, e0121303, 10.1371/journal.pone.0121303 Daneshvar, 2010, Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections, Malaria J., 9, 238, 10.1186/1475-2875-9-238 Grigg, 2015, Artesunate–mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial, Lancet Infect. Dis., 16, 180, 10.1016/S1473-3099(15)00415-6 William, 2011, Severe Plasmodium knowlesi malaria in a tertiary hospital, Sabah, Malaysia. Emerg. Infect. Dis., 17, 1248, 10.3201/eid1707.101017 Setiadi, 2016, A zoonotic human infection with simian malaria, Plasmodium knowlesi, in Central Kalimantan, Indonesia, Malaria J., 15, 1, 10.1186/s12936-016-1272-z 2015 Bronner, 2009, Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo, Malaria J., 8, 15, 10.1186/1475-2875-8-15 Tanizaki, 2013, First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia, Malaria J., 12, 1, 10.1186/1475-2875-12-128 Tripathi, 2005, Mefloquine resistance reversal action of ketoconazole–a cytochrome P 450 inhibitor, against mefloquine-resistant malaria, Parasitology, 130, 475, 10.1017/S0031182004006481 Singh, 1981, Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys, Indian J. Med. Res., 73, 23 Lau, 2011, Plasmodium knowlesi reinfection in human, Emerg. Infect. Dis., 17, 1314, 10.3201/eid1707.101295 Cox-Singh, 2008, Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening, Clin. Infect. Dis., 46, 165, 10.1086/524888 Phillips-Howard, 1995, CNS adverse events associated with antimalarial agents, Drug Saf., 12, 370, 10.2165/00002018-199512060-00003 Ehrhardt, 2013, Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand, Malaria J., 12, 283, 10.1186/1475-2875-12-283 Figtree, 2010, Plasmodium knowlesi in human, Indonesian Borneo, Emerg. Infect. Dis., 16, 672, 10.3201/eid1604.091624 Hoosen, 2011, Plasmodium knowlesi in a traveller returning to New Zealand, Travel. Med. Infect. Dis., 9, 144, 10.1016/j.tmaid.2011.03.002 Mackroth, 2016, Rapid-antigen test negative malaria in a traveler returning from Thailand, molecularly diagnosed as Plasmodium knowlesi, Open Forum Infect. Dis., 3, ofw039, 10.1093/ofid/ofw039 Douglas, 2010, Artemisinin combination therapy for vivax malaria, Lancet Infect. Dis., 10, 405, 10.1016/S1473-3099(10)70079-7 Grigg, 2016, Efficacy of artesunate-mefloquine against high-grade chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label randomised controlled trial, Clin. Infect. Dis., 62, 1403, 10.1093/cid/ciw121 Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect. Dis., 14, 982, 10.1016/S1473-3099(14)70855-2 van Hellemond, 2009, Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria, Emerg. Infect. Dis, 15, 1478, 10.3201/eid1509.090358 Nakaviroj, 2015, An autochthonous case of severe Plasmodium knowlesi malaria in Thailand, Am. J. Trop. Med. Hyg., 92, 569, 10.4269/ajtmh.14-0610 Ninan, 2012, Plasmodium knowlesi malaria infection in human, Brunei Int. Med. J., 8, 358 Seilmaier, 2014, Severe Plasmodium knowlesi infection with multi-organ failure imported to Germany from Thailand/Myanmar, Malaria J, 13, 422, 10.1186/1475-2875-13-422 Orth, 2013, Plasmodium knowlesi infection imported to Germany, January 2013, Euro. Surveill., 18, 1, 10.2807/1560-7917.ES2013.18.40.20603 Dondorp, 2005, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, 366, 717, 10.1016/S0140-6736(05)67176-0 Dondorp, 2010, Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, Lancet, 376, 1647, 10.1016/S0140-6736(10)61924-1 Willmann, 2012, Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study, Malaria J., 11, 363, 10.1186/1475-2875-11-363 2014, Severe malaria, Trop. Med. Int. Health, 19, 7, 10.1111/tmi.12313_2 Jauréguiberry, 2014, Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins, Blood, 124, 167, 10.1182/blood-2014-02-555953 Gómez-Junyent, 2015, Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum, Enferm. Infecc. Microbiol. Clin. Barber, 2016, Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria, Malaria J., 15, 462, 10.1186/s12936-016-1514-0 Daneshvar, 2009, Clinical and laboratory features of human Plasmodium knowlesi infection, Clin. Infect. Dis., 49, 852, 10.1086/605439 Lee, 2010, Human Plasmodium knowlesi infections in Klang Valley, Peninsular Malaysia: a case series, Med. J. Malaysia, 65, 63 Hanson, 2014, The fluid management of adults with severe malaria, Crit. Care, 18, 1, 10.1186/s13054-014-0642-6 Hanson, 2013, Fluid resuscitation of adults with severe falciparum malaria: effects on acid-base status, renal function, and extravascular lung water, Crit. Care Med., 41, 972, 10.1097/CCM.0b013e31827466d2 Aung, 2015, The safety of a conservative fluid replacement strategy in adults hospitalised with malaria, PLoS ONE, 10, e0143062, 10.1371/journal.pone.0143062 Douglas, 2013, Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study, PLoS Med., 10, e1001575, 10.1371/journal.pmed.1001575 Barber, 2011, Plasmodium knowlesi malaria in children, Emerg. Infect. Dis., 17, 814, 10.3201/eid1705.101489 Barber, 2014, Plasmodium knowlesi malaria in pregnancy, J. Infect. Dis., 211, 1104, 10.1093/infdis/jiu562 Dellicour, 2015, Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya, Malaria J., 14, 1, 10.1186/s12936-015-0950-6 Moore, 2016, Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study, Lancet Infect. Dis., 16, 576, 10.1016/S1473-3099(15)00547-2 Berry, 2011, Case report: imported Plasmodium knowlesi malaria in a French tourist returning from Thailand, Am. J. Trop. Med. Hyg., 84, 535, 10.4269/ajtmh.2011.10-0622 Ennis, 2009, Simian malaria in a US traveler–New York, 2008, Morbid. Mortal. Weekly Rep., 58, 229 Fan, 2013, Plasmodium knowlesi infection: a diagnostic challenge, BMJ Case Rep., 10.1136/bcr-2013-009558 Kantele, 2008, Monkey malaria in a European traveler returning from Malaysia, Emerg. Infect. Dis., 14, 1434, 10.3201/eid1409.080170 Kuo, 2009, A case report of simian malaria, Plasmodium knowlesi, in a Taiwanese traveler from Palawan Island, the Philippines, Taiwan Epidemiol. Bull., 25, 178 Tang, 2010, First case of detection of Plasmodium knowlesi in Spain by Real Time PCR in a traveller from Southeast Asia, Malaria J., 9, 219, 10.1186/1475-2875-9-219 Link, L. et al. (2010) Molecular detection of Plasmodium knowlesi in a Dutch traveler by real-time PCR. J. Clin. Microbiol. 50, 2523–2524 Kroidl, 2015, [Monkey malaria (Plasmodium knowlesi infection) after travelling to Thailand], Dt. med. Wschr., 140, 815